Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DOSTARLIMAB-GXLY vs DOXAZOSIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DOSTARLIMAB-GXLY vs DOXAZOSIN: Safety Overview

Metric DOSTARLIMAB-GXLY DOXAZOSIN
Total FAERS Reports 504 4,741
Deaths Reported 55 256
Death Rate 10.9% 5.4%
Hospitalizations 126 2,065
Average Patient Age 67.4 yrs 67.2 yrs
% Female Patients 92.7% 33.8%
FDA Approval Date N/A Apr 17, 2018
Manufacturer N/A A-S Medication Solutions
Route N/A ORAL
Marketing Status Prescription Prescription